Skip to content

CuraScientific Corp.: 10-Q filed 2023-12-08

What CuraScientific Corp. reported in its quarterly report filed 2023-12-08 (fiscal Q3 2023): 39 published measures, 110 facts as tagged in accession 0001877788-23-000041.

This filing

Form
10-Q (quarterly report)
Filed
2023-12-08
Fiscal period
fiscal Q3 2023
Accession
0001877788-23-000041 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CuraScientific Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-09-301,616,630USD
At 2022-12-311,551,785USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-09-3026,400,558USD
At 2022-12-3171,059,778USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-09-30-24,783,928USD
At 2023-06-30-25,886,956USD
At 2023-03-31-69,995,608USD
At 2022-12-31-69,507,993USD
At 2022-09-30-68,617,504USD
At 2022-06-30-69,131,627USD
At 2022-03-31-71,031,486USD
At 2021-12-31-69,386,516USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2023-09-3040,911USD
At 2022-12-31130USD
At 2022-09-30176USD
At 2021-12-3123,360USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-5,716,479USD92
2023-01-01 to 2023-09-3035,354,203USD273
2023-04-01 to 2023-06-3041,274,946USD91
2023-01-01 to 2023-03-31-204,265USD90
2022-07-01 to 2022-09-30194,123USD92
2022-01-01 to 2022-09-30-3,609,708USD273
2022-04-01 to 2022-06-30763,704USD91
2022-01-01 to 2022-03-31-4,567,535USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-304,256USD273
2022-01-01 to 2022-09-30-253,664USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-01-01 to 2023-09-3097,686USD273
2022-01-01 to 2022-09-3014,914USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-07-01 to 2023-09-30230,274USD92
2023-01-01 to 2023-09-301,052,401USD273
2022-01-01 to 2022-09-3034,434USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-09-30365,985USD273
2022-01-01 to 2022-09-30245,394USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-20,948USD273
2022-01-01 to 2022-09-30-14,914USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-09-3017,321,330USD
At 2022-12-31-16,454,247USD

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-07-01 to 2023-09-30756,676,539shares92
2023-01-01 to 2023-09-30988,915,323shares273
2022-07-01 to 2022-09-306,393,433shares92
2022-01-01 to 2022-09-304,073,796shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-07-01 to 2023-09-300USD/shares92
2023-01-01 to 2023-09-300.12USD/shares273
2022-07-01 to 2022-09-303.03USD/shares92
2022-01-01 to 2022-09-30-0.89USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-01-01 to 2023-09-300.04USD/shares273
2022-07-01 to 2022-09-303.03USD/shares92
2022-01-01 to 2022-09-30-0.89USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-09-30171,253USD
At 2022-12-3186,917USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-66,000USD92
2023-01-01 to 2023-09-30534,000USD273
2022-07-01 to 2022-09-3085,000USD92
2022-01-01 to 2022-09-30375,000USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-885,500USD92
2023-01-01 to 2023-09-30-3,520,985USD273
2022-07-01 to 2022-09-30-614,949USD92
2022-01-01 to 2022-09-30-1,730,825USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-09-301,079,707USD
At 2022-12-3139,868USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-07-01 to 2023-09-30155,060USD92
2023-01-01 to 2023-09-30196,550USD273
2022-07-01 to 2022-09-30397,864USD92
2022-01-01 to 2022-09-301,211,471USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-09-3026,057,272USD
At 2022-12-3170,809,778USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-09-30854,812USD
At 2022-12-31330,489USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2023-09-301,868USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-07-01 to 2023-09-30995,179USD92
2023-01-01 to 2023-09-303,996,162USD273
2022-07-01 to 2022-09-30614,949USD92
2022-01-01 to 2022-09-301,752,745USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2023-09-3044,824USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2023-07-01 to 2023-09-30109,679USD92
2023-01-01 to 2023-09-30475,177USD273
2022-01-01 to 2022-09-3021,920USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2023-07-01 to 2023-09-30120,595USD92
2023-01-01 to 2023-09-30577,224USD273
2022-01-01 to 2022-09-3012,514USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-09-302,629,582,856shares
At 2022-12-316,659,375shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-09-30-44,888,216USD
At 2022-12-31-53,954,412USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-09-30115,896USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2023-09-30278,214USD
At 2022-12-31180,528USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2023-09-30106,961USD
At 2022-12-3193,611USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-09-30992,104USD
At 2022-12-3139,738USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-07-01 to 2023-09-30248,229USD92
2023-01-01 to 2023-09-30584,009USD273
2022-07-01 to 2022-09-3068,505USD92
2022-01-01 to 2022-09-30336,040USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2023-07-01 to 2023-09-304,895USD92
2023-01-01 to 2023-09-3013,350USD273
2022-07-01 to 2022-09-304,252USD92
2022-01-01 to 2022-09-3012,007USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-07-01 to 2023-09-30-4,830,979USD92
2023-01-01 to 2023-09-3038,875,188USD273
2022-07-01 to 2022-09-30809,072USD92
2022-01-01 to 2022-09-30-1,878,883USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-01-01 to 2022-09-303,336USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-30-1,868USD273
2022-01-01 to 2022-09-3016,693USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-3056,746USD273
2022-01-01 to 2022-09-30-5,285USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-09-30281,806USD273
2022-01-01 to 2022-09-30175,230USD273

Inspect the source

Entity
CuraScientific Corp. / CIK 0001877788
Captured
SEC response SHA-256
04caedf3c98c4f3c85fe6df52375d02db291287bcba2f11a65f326e7bca641e5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001877788.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))